To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects.

ConditionNormal Skin
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNovoBliss Research Pvt Ltd

About this trial

To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

Eligibility criteria

Qualifiers

Subject scoring greater than 30 for Section 2 - Sensitive v/s Resistant skin in modified Dr Baumann's* skin type questionnaire.

Subject with sensitive skin as confirmed by Lactic Acid Stinging Test.

Disqualifiers

Subject having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks (e.g. tattoos (within the previous 3 months), scars, sunburn), open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) i.e. back that can interfere with the reading.

Medication which may affect skin response and/or past medical history. 3) Subject having history of diabetes 4) Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.

Trial design

Treatments tested in this trial

  • 1)0.1% Pinorox® Cream 2)1% Pinorox® Cream 3)Base cream 4)Positive control 5)Negative control

Treatment groups

26 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

NovoBliss Research Pvt Ltd

Lead sponsor

Ambe Phytoextracts Pvt. Ltd

Collaborator